Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE
Cancers · 10.02.2023 · 15 (4) · 1134
DOI: 10.3390/cancers15041134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 10.02.2023. Verfasst von Ragnar Bruvoll und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The aim of this paper was to investigate correlations between pre- therapeutic [68Ga]Ga-DOTA-TOC uptake and absorbed dose to tumours from therapy with [177Lu]Lu-DOTA-TATE.
Methods
This retrospective study included 301 tumours from 54 GEP-NET patients. The tumours were segmented on pre-therapeutic [68Ga]Ga-DOTA-TOC PET/CT, and post-therapy [177Lu]Lu-DOTA-TATE SPECT/CT images, using a fixed 40% threshold. The SPECT/CT images were used for absorbed dose calculations by assuming a linear build-up from time zero to day one, and mono-exponential wash-out after that. Both SUVmean and SUVmax were measured from the PET images. A linear absorbed-dose prediction model was formed with SUVmean as the independent variable, and the accuracy was tested with a split 70–30 training-test set.
Results
Mean SUVmean and SUVmax from [68Ga]Ga-DOTA-TOC PET was 24.0 (3.6–84.4) and 41.0 (6.7–146.5), and the mean absorbed dose from [177Lu]Lu-DOTA-TATE was 26.9 Gy (2.4–101.9). A linear relationship between SUVmean and [177Lu]Lu-DOTA-TATE activity concentration at 24 h post injection was found (R2 = 0.44, p < 0.05). In the prediction model, a root mean squared error and a mean absolute error of 1.77 and 1.33 Gy/GBq, respectively, were found for the test set.
Conclusions
There was a high inter- and intra-patient variability in tumour measurements, both for [68Ga]Ga-DOTA-TOC SUVs and absorbed doses from [177Lu]Lu-DOTA-TATE. Depending on the required accuracy, [68Ga]Ga-DOTA-TOC PET imaging may estimate the [177Lu]Lu-DOTA-TATE uptake. However, there could be a high variance between predicted and actual absorbed doses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway.
- Department of Physics, University of Oslo, 0315 Oslo, Norway.
- Department of Life Sciences and Health, Oslo Metropolitan University, 0130 Oslo, Norway.
ORCID-Profile: James Connelly, Caroline Stokke
Zitieren
APA
Bruvoll, R., Blakkisrud, J., Mikalsen, L. T., Connelly, J., & Stokke, C. (2023). Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE. Cancers, 15(4), 1134. https://doi.org/10.3390/cancers15041134
Vancouver
Bruvoll R, Blakkisrud J, Mikalsen LT, Connelly J, Stokke C. Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE. Cancers. 2023;15(4):1134. doi:10.3390/cancers15041134
BibTeX
@article{Bruvoll2023,
author = {Bruvoll, Ragnar and Blakkisrud, Johan and Mikalsen, Lars Tore and Connelly, James and Stokke, Caroline},
title = {Correlations between [68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE},
journal = {Cancers},
year = {2023},
volume = {15},
number = {4},
pages = {1134},
doi = {10.3390/cancers15041134}
}
EUVIMED